Industry Research Reports
Home > Reports > Chemical & Material > Bifidobacterium Longum Subsp. Infantis M-63 - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Bifidobacterium Longum Subsp. Infantis M-63 - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-03-10
Pages: 159 Pages
Report ld: 4517831
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Bifidobacterium Longum Subsp. Infantis M-63 Market Size(US$)
CAGR 2025-2031
6.2%
Market Size,2031
USD 67.7
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 47.2 million
Market Forecast in 2031(Value)
US$ 67.7 million
CAGR
6.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Bifidobacterium Longum Subsp. Infantis M-63 was estimated to be worth US$ 44.7 million in 2024 and is forecast to a readjusted size of US$ 67.7 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
North American market for Bifidobacterium Longum Subsp. Infantis M-63 was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bifidobacterium Longum Subsp. Infantis M-63 was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Bifidobacterium Longum Subsp. Infantis M-63 was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Bifidobacterium Longum Subsp. Infantis M-63 include Mitushi Biopharma, Fengchen Group, Jiangsu Wecare Biotechnology Co., Ltd., Shenzhen Lefu Biotechnology Co., Ltd., Hebei Hongtao Bioengineering Co., Ltd., Shandong Junle Biotechnology Co., Ltd., Shandong Xinxiong Biotechnology Co., Ltd., Newgen Biotech, Pharm-Rx, Rajvi Enterprise, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Bifidobacterium Longum Subsp. Infantis M-63, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bifidobacterium Longum Subsp. Infantis M-63 by region & country, by Type, and by Application.
The Bifidobacterium Longum Subsp. Infantis M-63 market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bifidobacterium Longum Subsp. Infantis M-63.
MARKET SEGMENTATION
By Company
- Mitushi Biopharma
- Fengchen Group
- Jiangsu Wecare Biotechnology Co., Ltd.
- Shenzhen Lefu Biotechnology Co., Ltd.
- Hebei Hongtao Bioengineering Co., Ltd.
- Shandong Junle Biotechnology Co., Ltd.
- Shandong Xinxiong Biotechnology Co., Ltd.
- Newgen Biotech
- Pharm-Rx
- Rajvi Enterprise
- Shandong Pingao Pharmaceutical Co., Ltd.
- Shaanxi Chenming Biotechnology Co., Ltd.
- Xi'an Minglang Biotechnology Co., Ltd.
- Jiahe Biotechnology (Shanxi) Co., Ltd.
- Shaanxi Ruimao Biotechnology Co., Ltd.
- Shaanxi Baohe Biotechnology Co., Ltd.
- Shaanxi Lesent Biotechnology Co., Ltd.
- Shaanxi Shuoyang Biotechnology Co., Ltd.
- Shaanxi Mufan Biotechnology Co., Ltd.
- Xi'an An'Drong Biomedical Technology Co., Ltd.
- Shaanxi Guanchen Biotechnology Co., Ltd.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 0-50 billion CFU/g
- 50-100 billion CFU/g
- ＞100 billion CFU/g
Segment by Application
- Food Additives
- Medicines and Supplements
- Feed Additives
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bifidobacterium Longum Subsp. Infantis M-63 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bifidobacterium Longum Subsp. Infantis M-63 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bifidobacterium Longum Subsp. Infantis M-63 in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Bifidobacterium Longum Subsp. Infantis M-63 Product Introduction
1.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size Forecast
1.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value (2020-2031)
1.2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume (2020-2031)
1.2.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Price (2020-2031)
1.3 Bifidobacterium Longum Subsp. Infantis M-63 Market Trends & Drivers
1.3.1 Bifidobacterium Longum Subsp. Infantis M-63 Industry Trends
1.3.2 Bifidobacterium Longum Subsp. Infantis M-63 Market Drivers & Opportunity
1.3.3 Bifidobacterium Longum Subsp. Infantis M-63 Market Challenges
1.3.4 Bifidobacterium Longum Subsp. Infantis M-63 Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Players Revenue Ranking (2024)
2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Company (2020-2025)
2.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Players Sales Volume Ranking (2024)
2.4 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Company Players (2020-2025)
2.5 Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Company (2020-2025)
2.6 Key Manufacturers Bifidobacterium Longum Subsp. Infantis M-63 Manufacturing Base and Headquarters
2.7 Key Manufacturers Bifidobacterium Longum Subsp. Infantis M-63 Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bifidobacterium Longum Subsp. Infantis M-63
2.9 Bifidobacterium Longum Subsp. Infantis M-63 Market Competitive Analysis
2.9.1 Bifidobacterium Longum Subsp. Infantis M-63 Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Bifidobacterium Longum Subsp. Infantis M-63 Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bifidobacterium Longum Subsp. Infantis M-63 as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 0-50 billion CFU/g
3.1.2 50-100 billion CFU/g
3.1.3 ＞100 billion CFU/g
3.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type
3.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, by Type (2020-2031)
3.2.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, by Type (%) (2020-2031)
3.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Type
3.3.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume, by Type (2020-2031)
3.3.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume, by Type (%) (2020-2031)
3.4 Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food Additives
4.1.2 Medicines and Supplements
4.1.3 Feed Additives
4.1.4 Others
4.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application
4.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, by Application (2020-2031)
4.2.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, by Application (%) (2020-2031)
4.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Application
4.3.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume, by Application (2020-2031)
4.3.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume, by Application (%) (2020-2031)
4.4 Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region
5.1.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region (2020-2025)
5.1.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region (2026-2031)
5.1.4 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region (%), (2020-2031)
5.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Region
5.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Region (2020-2025)
5.2.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Region (2026-2031)
5.2.4 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Region (%), (2020-2031)
5.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
5.4.2 North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
5.5.2 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
5.6.2 Asia Pacific Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
5.7.2 South America Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
5.8.2 Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bifidobacterium Longum Subsp. Infantis M-63 Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Bifidobacterium Longum Subsp. Infantis M-63 Sales Value and Sales Volume
6.2.1 Key Countries/Regions Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
6.2.2 Key Countries/Regions Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
6.3.2 United States Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
6.4.2 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
6.5.2 China Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
6.5.3 China Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
6.6.2 Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
6.7.2 South Korea Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
6.8.2 Southeast Asia Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020-2031
6.9.2 India Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
6.9.3 India Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Mitushi Biopharma
7.1.1 Mitushi Biopharma Company Information
7.1.2 Mitushi Biopharma Introduction and Business Overview
7.1.3 Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.1.5 Mitushi Biopharma Recent Development
7.2 Fengchen Group
7.2.1 Fengchen Group Company Information
7.2.2 Fengchen Group Introduction and Business Overview
7.2.3 Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.2.5 Fengchen Group Recent Development
7.3 Jiangsu Wecare Biotechnology Co., Ltd.
7.3.1 Jiangsu Wecare Biotechnology Co., Ltd. Company Information
7.3.2 Jiangsu Wecare Biotechnology Co., Ltd. Introduction and Business Overview
7.3.3 Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.3.5 Jiangsu Wecare Biotechnology Co., Ltd. Recent Development
7.4 Shenzhen Lefu Biotechnology Co., Ltd.
7.4.1 Shenzhen Lefu Biotechnology Co., Ltd. Company Information
7.4.2 Shenzhen Lefu Biotechnology Co., Ltd. Introduction and Business Overview
7.4.3 Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.4.5 Shenzhen Lefu Biotechnology Co., Ltd. Recent Development
7.5 Hebei Hongtao Bioengineering Co., Ltd.
7.5.1 Hebei Hongtao Bioengineering Co., Ltd. Company Information
7.5.2 Hebei Hongtao Bioengineering Co., Ltd. Introduction and Business Overview
7.5.3 Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.5.5 Hebei Hongtao Bioengineering Co., Ltd. Recent Development
7.6 Shandong Junle Biotechnology Co., Ltd.
7.6.1 Shandong Junle Biotechnology Co., Ltd. Company Information
7.6.2 Shandong Junle Biotechnology Co., Ltd. Introduction and Business Overview
7.6.3 Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.6.5 Shandong Junle Biotechnology Co., Ltd. Recent Development
7.7 Shandong Xinxiong Biotechnology Co., Ltd.
7.7.1 Shandong Xinxiong Biotechnology Co., Ltd. Company Information
7.7.2 Shandong Xinxiong Biotechnology Co., Ltd. Introduction and Business Overview
7.7.3 Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.7.5 Shandong Xinxiong Biotechnology Co., Ltd. Recent Development
7.8 Newgen Biotech
7.8.1 Newgen Biotech Company Information
7.8.2 Newgen Biotech Introduction and Business Overview
7.8.3 Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.8.5 Newgen Biotech Recent Development
7.9 Pharm-Rx
7.9.1 Pharm-Rx Company Information
7.9.2 Pharm-Rx Introduction and Business Overview
7.9.3 Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.9.5 Pharm-Rx Recent Development
7.10 Rajvi Enterprise
7.10.1 Rajvi Enterprise Company Information
7.10.2 Rajvi Enterprise Introduction and Business Overview
7.10.3 Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.10.5 Rajvi Enterprise Recent Development
7.11 Shandong Pingao Pharmaceutical Co., Ltd.
7.11.1 Shandong Pingao Pharmaceutical Co., Ltd. Company Information
7.11.2 Shandong Pingao Pharmaceutical Co., Ltd. Introduction and Business Overview
7.11.3 Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.11.5 Shandong Pingao Pharmaceutical Co., Ltd. Recent Development
7.12 Shaanxi Chenming Biotechnology Co., Ltd.
7.12.1 Shaanxi Chenming Biotechnology Co., Ltd. Company Information
7.12.2 Shaanxi Chenming Biotechnology Co., Ltd. Introduction and Business Overview
7.12.3 Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.12.5 Shaanxi Chenming Biotechnology Co., Ltd. Recent Development
7.13 Xi'an Minglang Biotechnology Co., Ltd.
7.13.1 Xi'an Minglang Biotechnology Co., Ltd. Company Information
7.13.2 Xi'an Minglang Biotechnology Co., Ltd. Introduction and Business Overview
7.13.3 Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.13.5 Xi'an Minglang Biotechnology Co., Ltd. Recent Development
7.14 Jiahe Biotechnology (Shanxi) Co., Ltd.
7.14.1 Jiahe Biotechnology (Shanxi) Co., Ltd. Company Information
7.14.2 Jiahe Biotechnology (Shanxi) Co., Ltd. Introduction and Business Overview
7.14.3 Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.14.5 Jiahe Biotechnology (Shanxi) Co., Ltd. Recent Development
7.15 Shaanxi Ruimao Biotechnology Co., Ltd.
7.15.1 Shaanxi Ruimao Biotechnology Co., Ltd. Company Information
7.15.2 Shaanxi Ruimao Biotechnology Co., Ltd. Introduction and Business Overview
7.15.3 Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.15.5 Shaanxi Ruimao Biotechnology Co., Ltd. Recent Development
7.16 Shaanxi Baohe Biotechnology Co., Ltd.
7.16.1 Shaanxi Baohe Biotechnology Co., Ltd. Company Information
7.16.2 Shaanxi Baohe Biotechnology Co., Ltd. Introduction and Business Overview
7.16.3 Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.16.5 Shaanxi Baohe Biotechnology Co., Ltd. Recent Development
7.17 Shaanxi Lesent Biotechnology Co., Ltd.
7.17.1 Shaanxi Lesent Biotechnology Co., Ltd. Company Information
7.17.2 Shaanxi Lesent Biotechnology Co., Ltd. Introduction and Business Overview
7.17.3 Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.17.5 Shaanxi Lesent Biotechnology Co., Ltd. Recent Development
7.18 Shaanxi Shuoyang Biotechnology Co., Ltd.
7.18.1 Shaanxi Shuoyang Biotechnology Co., Ltd. Company Information
7.18.2 Shaanxi Shuoyang Biotechnology Co., Ltd. Introduction and Business Overview
7.18.3 Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.18.5 Shaanxi Shuoyang Biotechnology Co., Ltd. Recent Development
7.19 Shaanxi Mufan Biotechnology Co., Ltd.
7.19.1 Shaanxi Mufan Biotechnology Co., Ltd. Company Information
7.19.2 Shaanxi Mufan Biotechnology Co., Ltd. Introduction and Business Overview
7.19.3 Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.19.5 Shaanxi Mufan Biotechnology Co., Ltd. Recent Development
7.20 Xi'an An'Drong Biomedical Technology Co., Ltd.
7.20.1 Xi'an An'Drong Biomedical Technology Co., Ltd. Company Information
7.20.2 Xi'an An'Drong Biomedical Technology Co., Ltd. Introduction and Business Overview
7.20.3 Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.20.5 Xi'an An'Drong Biomedical Technology Co., Ltd. Recent Development
7.21 Shaanxi Guanchen Biotechnology Co., Ltd.
7.21.1 Shaanxi Guanchen Biotechnology Co., Ltd. Company Information
7.21.2 Shaanxi Guanchen Biotechnology Co., Ltd. Introduction and Business Overview
7.21.3 Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
7.21.5 Shaanxi Guanchen Biotechnology Co., Ltd. Recent Development
8 Industry Chain Analysis
8.1 Bifidobacterium Longum Subsp. Infantis M-63 Industrial Chain
8.2 Bifidobacterium Longum Subsp. Infantis M-63 Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bifidobacterium Longum Subsp. Infantis M-63 Sales Model
8.5.2 Sales Channel
8.5.3 Bifidobacterium Longum Subsp. Infantis M-63 Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Bifidobacterium Longum Subsp. Infantis M-63 Market Trends
Table 2. Bifidobacterium Longum Subsp. Infantis M-63 Market Drivers & Opportunity
Table 3. Bifidobacterium Longum Subsp. Infantis M-63 Market Challenges
Table 4. Bifidobacterium Longum Subsp. Infantis M-63 Market Restraints
Table 5. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Market Share by Company (2020-2025)
Table 7. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Company (2020-2025) & (Tons)
Table 8. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Bifidobacterium Longum Subsp. Infantis M-63 Price by Company (2020-2025) & (US$/Ton)
Table 10. Key Manufacturers Bifidobacterium Longum Subsp. Infantis M-63 Manufacturing Base and Headquarters
Table 11. Key Manufacturers Bifidobacterium Longum Subsp. Infantis M-63 Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Bifidobacterium Longum Subsp. Infantis M-63
Table 13. Global Bifidobacterium Longum Subsp. Infantis M-63 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bifidobacterium Longum Subsp. Infantis M-63 as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share in Value by Type (2020-2025)
Table 20. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share in Value by Type (2026-2031)
Table 21. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Type (2020-2025) & (Tons)
Table 23. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Type (2026-2031) & (Tons)
Table 24. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Type (2020-2025) & (US$/Ton)
Table 27. Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Type (2026-2031) & (US$/Ton)
Table 28. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share in Value by Application (2020-2025)
Table 32. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share in Value by Application (2026-2031)
Table 33. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
Table 34. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Application (2020-2025) & (Tons)
Table 35. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Application (2026-2031) & (Tons)
Table 36. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Application (2020-2025) & (US$/Ton)
Table 39. Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Application (2026-2031) & (US$/Ton)
Table 40. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region (2020-2025) & (%)
Table 44. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region (2026-2031) & (%)
Table 45. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
Table 46. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Region (2020-2025) & (Tons)
Table 47. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Region (2026-2031) & (Tons)
Table 48. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Region (2020-2025) & (%)
Table 49. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Region (2026-2031) & (%)
Table 50. Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Region (2020-2025) & (US$/Ton)
Table 51. Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Region (2026-2031) & (US$/Ton)
Table 52. Key Countries/Regions Bifidobacterium Longum Subsp. Infantis M-63 Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume, (2020-2025) & (Tons)
Table 56. Key Countries/Regions Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume, (2026-2031) & (Tons)
Table 57. Mitushi Biopharma Company Information
Table 58. Mitushi Biopharma Introduction and Business Overview
Table 59. Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 60. Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 61. Mitushi Biopharma Recent Development
Table 62. Fengchen Group Company Information
Table 63. Fengchen Group Introduction and Business Overview
Table 64. Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 65. Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 66. Fengchen Group Recent Development
Table 67. Jiangsu Wecare Biotechnology Co., Ltd. Company Information
Table 68. Jiangsu Wecare Biotechnology Co., Ltd. Introduction and Business Overview
Table 69. Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 70. Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 71. Jiangsu Wecare Biotechnology Co., Ltd. Recent Development
Table 72. Shenzhen Lefu Biotechnology Co., Ltd. Company Information
Table 73. Shenzhen Lefu Biotechnology Co., Ltd. Introduction and Business Overview
Table 74. Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 76. Shenzhen Lefu Biotechnology Co., Ltd. Recent Development
Table 77. Hebei Hongtao Bioengineering Co., Ltd. Company Information
Table 78. Hebei Hongtao Bioengineering Co., Ltd. Introduction and Business Overview
Table 79. Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 81. Hebei Hongtao Bioengineering Co., Ltd. Recent Development
Table 82. Shandong Junle Biotechnology Co., Ltd. Company Information
Table 83. Shandong Junle Biotechnology Co., Ltd. Introduction and Business Overview
Table 84. Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 86. Shandong Junle Biotechnology Co., Ltd. Recent Development
Table 87. Shandong Xinxiong Biotechnology Co., Ltd. Company Information
Table 88. Shandong Xinxiong Biotechnology Co., Ltd. Introduction and Business Overview
Table 89. Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 91. Shandong Xinxiong Biotechnology Co., Ltd. Recent Development
Table 92. Newgen Biotech Company Information
Table 93. Newgen Biotech Introduction and Business Overview
Table 94. Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 96. Newgen Biotech Recent Development
Table 97. Pharm-Rx Company Information
Table 98. Pharm-Rx Introduction and Business Overview
Table 99. Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 101. Pharm-Rx Recent Development
Table 102. Rajvi Enterprise Company Information
Table 103. Rajvi Enterprise Introduction and Business Overview
Table 104. Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 106. Rajvi Enterprise Recent Development
Table 107. Shandong Pingao Pharmaceutical Co., Ltd. Company Information
Table 108. Shandong Pingao Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 109. Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 111. Shandong Pingao Pharmaceutical Co., Ltd. Recent Development
Table 112. Shaanxi Chenming Biotechnology Co., Ltd. Company Information
Table 113. Shaanxi Chenming Biotechnology Co., Ltd. Introduction and Business Overview
Table 114. Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 116. Shaanxi Chenming Biotechnology Co., Ltd. Recent Development
Table 117. Xi'an Minglang Biotechnology Co., Ltd. Company Information
Table 118. Xi'an Minglang Biotechnology Co., Ltd. Introduction and Business Overview
Table 119. Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 120. Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 121. Xi'an Minglang Biotechnology Co., Ltd. Recent Development
Table 122. Jiahe Biotechnology (Shanxi) Co., Ltd. Company Information
Table 123. Jiahe Biotechnology (Shanxi) Co., Ltd. Introduction and Business Overview
Table 124. Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 125. Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 126. Jiahe Biotechnology (Shanxi) Co., Ltd. Recent Development
Table 127. Shaanxi Ruimao Biotechnology Co., Ltd. Company Information
Table 128. Shaanxi Ruimao Biotechnology Co., Ltd. Introduction and Business Overview
Table 129. Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 130. Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 131. Shaanxi Ruimao Biotechnology Co., Ltd. Recent Development
Table 132. Shaanxi Baohe Biotechnology Co., Ltd. Company Information
Table 133. Shaanxi Baohe Biotechnology Co., Ltd. Introduction and Business Overview
Table 134. Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 135. Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 136. Shaanxi Baohe Biotechnology Co., Ltd. Recent Development
Table 137. Shaanxi Lesent Biotechnology Co., Ltd. Company Information
Table 138. Shaanxi Lesent Biotechnology Co., Ltd. Introduction and Business Overview
Table 139. Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 140. Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 141. Shaanxi Lesent Biotechnology Co., Ltd. Recent Development
Table 142. Shaanxi Shuoyang Biotechnology Co., Ltd. Company Information
Table 143. Shaanxi Shuoyang Biotechnology Co., Ltd. Introduction and Business Overview
Table 144. Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 145. Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 146. Shaanxi Shuoyang Biotechnology Co., Ltd. Recent Development
Table 147. Shaanxi Mufan Biotechnology Co., Ltd. Company Information
Table 148. Shaanxi Mufan Biotechnology Co., Ltd. Introduction and Business Overview
Table 149. Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 150. Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 151. Shaanxi Mufan Biotechnology Co., Ltd. Recent Development
Table 152. Xi'an An'Drong Biomedical Technology Co., Ltd. Company Information
Table 153. Xi'an An'Drong Biomedical Technology Co., Ltd. Introduction and Business Overview
Table 154. Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 155. Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 156. Xi'an An'Drong Biomedical Technology Co., Ltd. Recent Development
Table 157. Shaanxi Guanchen Biotechnology Co., Ltd. Company Information
Table 158. Shaanxi Guanchen Biotechnology Co., Ltd. Introduction and Business Overview
Table 159. Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 160. Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Offerings
Table 161. Shaanxi Guanchen Biotechnology Co., Ltd. Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Bifidobacterium Longum Subsp. Infantis M-63 Downstream Customers
Table 165. Bifidobacterium Longum Subsp. Infantis M-63 Distributors List
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Bifidobacterium Longum Subsp. Infantis M-63 Product Picture
Figure 2. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume (2020-2031) & (Tons)
Figure 5. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Price (2020-2031) & (US$/Ton)
Figure 6. Bifidobacterium Longum Subsp. Infantis M-63 Report Years Considered
Figure 7. Global Bifidobacterium Longum Subsp. Infantis M-63 Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Bifidobacterium Longum Subsp. Infantis M-63 Players Sales Volume Ranking (2024) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bifidobacterium Longum Subsp. Infantis M-63 Revenue in 2024
Figure 10. Bifidobacterium Longum Subsp. Infantis M-63 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. 0-50 billion CFU/g Picture
Figure 12. 50-100 billion CFU/g Picture
Figure 13. ＞100 billion CFU/g Picture
Figure 14. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
Figure 17. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Type (2020-2031) & (US$/Ton)
Figure 19. Product Picture of Food Additives
Figure 20. Product Picture of Medicines and Supplements
Figure 21. Product Picture of Feed Additives
Figure 22. Product Picture of Others
Figure 23. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 24. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Value Market Share by Application, 2024 & 2031
Figure 25. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
Figure 26. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume Market Share by Application, 2024 & 2031
Figure 27. Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Application (2020-2031) & (US$/Ton)
Figure 28. North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Bifidobacterium Longum Subsp. Infantis M-63 Sales Value (%), (2020-2031)
Figure 39. Key Countries/Regions Bifidobacterium Longum Subsp. Infantis M-63 Sales Volume (%), (2020-2031)
Figure 40. United States Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2031) & (US$ Million)
Figure 41. United States Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
Figure 42. United States Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application (%), 2024 VS 2031
Figure 43. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2031) & (US$ Million)
Figure 44. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
Figure 45. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application (%), 2024 VS 2031
Figure 46. China Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2031) & (US$ Million)
Figure 47. China Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
Figure 48. China Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application (%), 2024 VS 2031
Figure 49. Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2031) & (US$ Million)
Figure 50. Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
Figure 51. Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application (%), 2024 VS 2031
Figure 52. South Korea Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2031) & (US$ Million)
Figure 53. South Korea Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
Figure 54. South Korea Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application (%), 2024 VS 2031
Figure 55. Southeast Asia Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2031) & (US$ Million)
Figure 56. Southeast Asia Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
Figure 57. Southeast Asia Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application (%), 2024 VS 2031
Figure 58. India Bifidobacterium Longum Subsp. Infantis M-63 Sales Value, (2020-2031) & (US$ Million)
Figure 59. India Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Type (%), 2024 VS 2031
Figure 60. India Bifidobacterium Longum Subsp. Infantis M-63 Sales Value by Application (%), 2024 VS 2031
Figure 61. Bifidobacterium Longum Subsp. Infantis M-63 Industrial Chain
Figure 62. Bifidobacterium Longum Subsp. Infantis M-63 Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Bifidobacterium Longum Subsp. Infantis M-63 market?
The top companies in the global Bifidobacterium Longum Subsp. Infantis M-63 market are Mitushi Biopharma、Fengchen Group、Jiangsu Wecare Biotechnology Co., Ltd..
Which region is expected to have the highest market share?
What was the global market size of Bifidobacterium Longum Subsp. Infantis M-63 in 2025?
What is the annual compound growth rate of the global Bifidobacterium Longum Subsp. Infantis M-63 market size from 2025 to 2031?
What was the global market size of Bifidobacterium Longum Subsp. Infantis M-63 in 2031?
Related Reports
Global Bifidobacterium Longum Subsp. Infantis M-63 Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Bifidobacterium Longum Subsp. Infantis M-63 market is projected to grow from US$ 47.19 million in 2025 to US$ 71.49 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 200
USD 4900.00
(Single User License)
Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bifidobacterium Longum Subsp. Infantis M-63 market size was US$ 47.19 million in 2025 and is forecast to reach a readjusted size of US$ 71.49 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 115
USD 4250.00
(Single User License)
Bifidobacterium Longum Subsp. Infantis M-63- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bifidobacterium Longum Subsp. Infantis M-63 was estimated to be worth US$ 47.19 million in 2025 and is projected to reach US$ 71.49 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 154
USD 3950.00
(Single User License)
Global Bifidobacterium Longum Subsp. Infantis M-63 Market Research Report 2026
The global Bifidobacterium Longum Subsp. Infantis M-63 market was valued at US$ 47.19 million in 2025 and is anticipated to reach US$ 71.49 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 163
USD 2900.00
(Single User License)
Global Bifidobacterium Longum Subsp. Infantis M-63 Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Bifidobacterium Longum Subsp. Infantis M-63 market is projected to grow from US$ 44.7 million in 2024 to US$ 67.7 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 190
USD 4900.00
(Single User License)
Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bifidobacterium Longum Subsp. Infantis M-63 market size was US$ 44.7 million in 2024 and is forecast to a readjusted size of US$ 67.7 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 112
USD 4250.00
(Single User License)
Global Bifidobacterium Longum Subsp. Infantis M-63 Market Research Report 2025
The global market for Bifidobacterium Longum Subsp. Infantis M-63 was valued at US$ 44.7 million in the year 2024 and is projected to reach a revised size of US$ 67.7 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published Date: 2025-03-10
Pages: 120
USD 2900.00
(Single User License)
Global and United States Bifidobacterium Longum Subsp. Infantis M-63 Market Report & Forecast 2024-2030
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published Date: 2024-09-11
Pages: 172
USD 4350.00
(Single User License)
Global Bifidobacterium Longum Subsp. Infantis M-63 Market Insights, Forecast to 2030
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published Date: 2024-09-11
Pages: 193
USD 4900.00
(Single User License)
Global Bifidobacterium Longum Subsp. Infantis M-63 Market Research Report 2024
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published Date: 2024-09-11
Pages: 120
USD 2900.00
(Single User License)
Global Bifidobacterium Longum Subsp. Infantis M-63 Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Bifidobacterium Longum Subsp. Infantis M-63 market is projected to grow from US$ 47.19 million in 2025 to US$ 71.49 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 200
USD 4900.00 (Single User License)Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bifidobacterium Longum Subsp. Infantis M-63 market size was US$ 47.19 million in 2025 and is forecast to reach a readjusted size of US$ 71.49 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 115
USD 4250.00 (Single User License)Bifidobacterium Longum Subsp. Infantis M-63- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bifidobacterium Longum Subsp. Infantis M-63 was estimated to be worth US$ 47.19 million in 2025 and is projected to reach US$ 71.49 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-01-09
Pages: 154
USD 3950.00 (Single User License)Global Bifidobacterium Longum Subsp. Infantis M-63 Market Research Report 2026
The global Bifidobacterium Longum Subsp. Infantis M-63 market was valued at US$ 47.19 million in 2025 and is anticipated to reach US$ 71.49 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-01-09
Pages: 163
USD 2900.00 (Single User License)Global Bifidobacterium Longum Subsp. Infantis M-63 Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Bifidobacterium Longum Subsp. Infantis M-63 market is projected to grow from US$ 44.7 million in 2024 to US$ 67.7 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 190
USD 4900.00 (Single User License)Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bifidobacterium Longum Subsp. Infantis M-63 market size was US$ 44.7 million in 2024 and is forecast to a readjusted size of US$ 67.7 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 112
USD 4250.00 (Single User License)Global Bifidobacterium Longum Subsp. Infantis M-63 Market Research Report 2025
The global market for Bifidobacterium Longum Subsp. Infantis M-63 was valued at US$ 44.7 million in the year 2024 and is projected to reach a revised size of US$ 67.7 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published: 2025-03-10
Pages: 120
USD 2900.00 (Single User License)Global and United States Bifidobacterium Longum Subsp. Infantis M-63 Market Report & Forecast 2024-2030
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published: 2024-09-11
Pages: 172
USD 4350.00 (Single User License)Global Bifidobacterium Longum Subsp. Infantis M-63 Market Insights, Forecast to 2030
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published: 2024-09-11
Pages: 193
USD 4900.00 (Single User License)Global Bifidobacterium Longum Subsp. Infantis M-63 Market Research Report 2024
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published: 2024-09-11
Pages: 120
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now